FDA Inspection 1293354 — Susheel K. Kodali, M.D.
The FDA completed an inspection of Susheel K. Kodali, M.D. on November 26, 2025 in New York, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Devices.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- November 26, 2025
- Fiscal Year
- 2026
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- New York, NY (United States)
Additional Details
Clinical Investigator (CI)
Citations
| ID | CFR | Description |
|---|---|---|
| 3021 | 21 CFR 812.150(a)(1) | Investigator report of unanticipated adverse effects |